Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 EV-to-FCF is -5.99 as of Jul. 26, 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,191 Consumer Packaged Goods companies, Sheel Biotech ranks worse than 83962.97% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sheel Biotech's Enterprise Value is ₹1,452 Mil.
Sheel Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-242 Mil. Therefore, Sheel Biotech's EV-to-FCF for today is -5.99.
The historical rank and industry rank for Sheel Biotech's EV-to-FCF or its related term are showing as below:
NSE:SHEEL'
s EV-to-FCF Range Over the Past 10 Years
Min: -5.99 Med: 18.93 Max: 26.46
Current: -5.99
During the past 5 years, the highest EV-to-FCF of Sheel Biotech was 26.46. The lowest was -5.99. And the median was 18.93.
NSE:SHEEL's EV-to-FCF is ranked worse than 100% of 1191
companies
in the Consumer Packaged Goods industry
Industry Median: 15.91
vs NSE:SHEEL: -5.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sheel Biotech's PE Ratio (TTM) for today is calculated as:
Sheel Biotech's share price for today is ₹68.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹6.690.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sheel Biotech EV-to-FCF Related Terms
Sheel Biotech EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech EV-to-FCF Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
EV-to-FCF
0.00
0.00
0.00
0.00
-3.64
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
EV-to-FCF
0.00
0.00
0.00
0.00
-3.64
NSE:SHEEL vs ADM, BG, TSN: EV-to-FCF Comparison
For the Farm Products subindustry, Sheel Biotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's EV-to-FCF falls into.
Sheel Biotech's current Enterprise Value is ₹1,452 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sheel Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-242 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech (NSE:SHEEL) has a EV-to-FCF of -5.99 as of Jul. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sheel Biotech and its competitors. According to the industry distribution chart, Sheel Biotech ranks #999999 out of 1191 companies in the Consumer Packaged Goods industry.
Is Sheel Biotech's EV-to-FCF too high?
Sheel Biotech's current EV-to-FCF is -5.99. Based on the distribution chart, Sheel Biotech ranks #999999 out of 1191 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's EV-to-FCF compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #999999 out of 1191 companies for EV-to-FCF. This places Sheel Biotech in the lower half of its industry. The industry median EV-to-FCF is 15.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.91, based on 1,191 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current EV-to-FCF is -5.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current EV-to-FCF of -5.99. The current EV-to-FCF is -5.99. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current EV-to-FCF is -5.99 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
